Aflatoxin exposure in viral hepatitis patients in Turkey

Turkish Journal of Gastroenterology

Volumn 20, Issue 3, 2009, Pages 192-197

  Mizrak, Dilša ^a   Engin, Başlak ^b   Önder, Fatih Oǧuz ^a   Yener, Burcu ^a   Bektaš, Mehmet ^a   Biyikli, Zeynep ^a   Idilman, Ramazan ^a   Çinar, Kubilay ^a   Karayalçin, Kaan ^a   Ersöz, Sadik ^a   Karayalçin, Selim ^a   Özden, Ali ^a   Yurdaydin, Cihan ^a   Yazihan, Nuray ^a   Ataoǧlu, Haluk ^a   Bozkaya, Hakan ^a   Uzunalimoǧlu, Özden ^c  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c Turkish Geriatric Foundation   (Turkey)

Author keywords

Aflatoxin; Chronic hepatitis; Cirrhosis; Hepatocellular carcinoma; Viral hepatitis

Indexed keywords

AFLATOXIN B1; AFLATOXIN B2; AFLATOXIN G1; AFLATOXIN G2;

ARTICLE; BLOOD ANALYSIS; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; SOCIOECONOMICS; TURKEY (REPUBLIC); VIRUS HEPATITIS; VIRUS INFECTION;

AFLATOXINS; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; POISONS; RISK FACTORS; SOCIOECONOMIC FACTORS; TURKEY;

EID: 70350176474     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2009.0006     Document Type: Article

References (32)

1. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35: 72-78
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841
3. Stewart BW, Kleihues P. World Cancer Report. Lyon: IARC Press, 2003.
4. Okuda K. Epidemiology of primary liver cancer. In: Tobe T, ed. Primary liver cancer in Japan. Tokyo: Springer-Verlag, 1992; 3.
5. Prates MD, Torres FO. A cancer survey in Lourenco Marques, Portuguese East Africa. J Natl Cancer Inst 1965; 35: 729.
6. Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998; 27: 914-919 (Pubitemid 28160474)
7. Sun Z, Lu P, Gail MH, et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 1999; 30: 379-383 (Pubitemid 29357500)
8. Tseng T. Recent aspects of aflatoxin research in Taiwan. J Toxicology Toxin Rev 1994; 13: 229-241
9. Bressac B, Kew M, Wands J, Öztürk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429-431 (Pubitemid 21912246)
10. Ross RK, Yuan JM, Yu MC, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943-946
11. Qian GS, Ross RK, Yu MC, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3: 3-10.
12. Aguilar F, Perez Hussain S, Cerruti P. Aflatoxin B1 induces the transversion of G --> T in the codon 249 of the tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 1993; 90: 8586-8590
13. Montesano R, Hainaut P, Wild CP. Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 1997; 89: 1844-1851 (Pubitemid 28009820)
14. Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int 2003; 23: 405-409 (Pubitemid 37540977)
15. fienyuva HZ, Gilbert J, Ülken U. Aflatoxins in Turkish dried figs intended for export to the European Union. J Food Prot 2007; 70: 1029-1032
16. Karaca H, Nas S. Aflatoxins, patulin, and ergosterol contents of dried figs in Turkey. Food Addit Contam 2006; 23: 502-508 (Pubitemid 43675285)
17. Erdoǧan A. The aflatoxin contamination of some pepper types sold in Turkey. Chemosphere 2004; 56: 321-325 (Pubitemid 38746682)
18. Gunsen U, Büyükyörük I. Aflatoxins in retail food products in Bursa, Turkey. Vet Hum Toxicol 2002; 44: 289-290
19. Nilüfer D, Boyacioǧlu D. Comparative study of three different methods for the determination of aflatoxins in tahini. J Agric Food Chem 2002; 50: 3375-3379 (Pubitemid 34579262)
20. Kivanç M. Fungal contamination of Kashar cheese in Turkey. Nahrung 1992; 36: 578-583
21. Wild CP, Hasegawa R, Barraud L, et al. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and man. Cancer Epidemiol Biomarkers Prev 1996; 5: 179-189 (Pubitemid 26088267)
22. Jelinek CF, Pohland AE, Wood GE. Worldwide occurrence of mycotoxins in foods and feeds - an update. J Assoc Off Anal Chem 1989; 72: 223-230
23. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004; 127: 72-78.
24. Wang LY, Hatch M, Chen CJ, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996; 67: 620-625 (Pubitemid 26300976)
25. Sell S, Hunt JM, Dunsford HA, Chisari FV. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res 1991; 51: 1278-1285
26. Bannasch P, Khoshkhou NI, Hacker HJ, et al. Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks. Cancer Res 1995; 55: 3318-3330
27. Chemin I, Ohgaki H, Chisari FV, et al. Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen. Liver 1999; 19: 81-87 (Pubitemid 29139759)
28. Yu MW, Lien JP, Chiu YH, et al. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol 1997; 27: 120-130
29. Sun CA, Wang LY, Chen CJ, et al. Genetic polymorphisms of glutathione-S-transferases M1 and T1 associated with susceptibility to aflatoxin-related carcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis 2001; 22: 1289-94.
30. Chen CJ, Yu MW, Liaw YF, et al. Chronic hepatitis B carriers with null genotypes glutathione-S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 1996; 59: 128-34.
31. Ozturk M, Bressac B, Pusieux A, et al. A p53 mutational hotspot in primary liver cancer is geographically localized to high aflatoxin areas of the world. Lancet 1991; 338: 260-5.
32. Stern MC, Umbach DM, Yu MC, et al. Hepatitis B, aflatoxin B1, and p53 codon 249 mutation in hepatocellular carcinoma from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol Biomarkers Prev 2001; 10: 617-25.